MDaudit announced it will acquire all outstanding shares of Streamline Health Solutions, Inc. (STRM) for $5.34 per share in cash, representing a 138 percent premium to Streamline's May 28 closing price.
The all-cash transaction is valued at approximately $37.4 million, including debt.
The merger combines MDaudit's billing compliance and revenue integrity platform with Streamline's pre-bill solutions, eValuator and RevID, to deliver real-time, AI-driven visibility across the healthcare revenue cycle.
The companies stated that the integration aims to improve financial stability for health systems through unified data and actionable insights.
At the effective time of the merger, Streamline will become a wholly-owned subsidiary of MDaudit and its shares will be delisted from the Nasdaq.
The deal is expected to close in the third quarter 2025, subject to customary closing conditions and shareholder approval.
MDaudit has secured voting agreements from Streamline executives and affiliates holding approximately 22 percent of the company's outstanding shares.
The transaction is not subject to financing conditions and will be funded through MDaudit's cash reserves and existing credit facilities.
No unexpected conditions or regulatory hurdles are anticipated, both companies said.
Currently, STRM is trading at $5.0, up by 125.2 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.